Method of detecting schizophrenia risk
OwnerPhilip Seeman, Gabriela Novak +1inventors
InventorsPhilip Seeman, Gabriela Novak, Teresa Tallerico
Life of this patent
Estimating the term…
Abstract
Methods and kits for determining susceptibility of a patient to neuropsychiatric disorders are described. The method involves analyzing a sample comprising nucleic acids from a patient for a polymorphism of the Nogo gene.
Claims19
A method of determining the susceptibility of a patient to a neuropsychiatric disorder comprising:
- (a) obtaining a sample from a patient;
- and
- (b) testing the sample for the presence of a polymorphism in the Nogo gene, wherein the presence of a polymorphism indicates that the patient is susceptible to a neuropsychiatric disorder.
A method of diagnosing a neuropsychiatric disorder in a patient by analyzing for a presence of a polymorphism in the Nogo gene in a biological sample obtained from the patient, wherein the presence of a polymorphism in the Nogo gene, indicates a likelihood that the patient is suffering from a neuropsychiatric disorder.
A method of determining if a patient will have increased symptomatology associated with a neuropsychiatric disorder by analyzing for a presence of a polymorphism in the Nogo gene in a biological sample obtained from the patient, wherein the presence of a polymorphism in the Nogo gene, indicates a likelihood that the patient will have increased symptomatology associated with a neuropsychiatric disorder.
Dependencies are inferred from the claim text.